Photo by impulsq from unsplash
A differential diagnosis between malignant and benign parathyroid lesions is difficult due to their overlapping clinicopathological characteristics. As such, molecular markers are urgently needed. Cancer‐derived immunoglobulin G (CIgG) is a… Click to show full abstract
A differential diagnosis between malignant and benign parathyroid lesions is difficult due to their overlapping clinicopathological characteristics. As such, molecular markers are urgently needed. Cancer‐derived immunoglobulin G (CIgG) is a novel molecule playing important roles in carcinogenesis. The present study aimed to investigate the clinical significance of CIgG in parathyroid neoplasms.
Keywords:
differential diagnosis;
cancer derived;
parathyroid;
derived immunoglobulin
Journal Title: Clinical Endocrinology
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Clinical Endocrinology
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!